Literature DB >> 7635779

Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation.

F Zywietz1, W Reeker, E Kochs.   

Abstract

PURPOSE: To quantify the changes in tumor oxygenation in the course of a fractionated radiation treatment extending over 4 weeks. METHODS AND MATERIALS: Rhabdomyosarcomas R1H of the rat were irradiated with 60Co-gamma-rays with a total dose of 60 Gy, given in 20 fractions over 4 weeks. Oxygen partial pressure (pO2) in tumors was measured at weekly intervals using polarographic needle probes in combination with a microprocessor-controlled device (pO2-Histograph/KIMOC). The pO2 measurements were carried out in anesthetized animals under mechanical ventilation and in respiratory and hemodynamic steady state. Tumor pO2 values were correlated to the arterial oxygen pressure paO2, arterial pCO2, and pH determined with a blood gas analyzer.
RESULTS: Tumor oxygenation did not change significantly during the 3 weeks of irradiation (up to 45 Gy), from a median pO2 of 23 +/- 2 mmHg in untreated controls to 19 +/- 4 mmHg after the third week. The decrease of the number of pO2 values between 0 and 5 mmHg indicated that an improved oxygenation in the tumors occurred. However, with increasing radiation dose (fourth week, 60 Gy) a significant decrease in tumor oxygenation to a median pO2 of 8 +/- 2 mmHg and a rapid increase in the frequency of pO2 values (35 +/- 4%) between 0 and 5 mmHg was found.
CONCLUSION: Improved oxygenation in rhabdomyosarcomas R1H was only present in the early phase of the fractionated irradiation. Radiation does above 45 Gy led to a considerable decrease of tumor oxygenation in the later phase of irradiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635779     DOI: 10.1016/0360-3016(94)00653-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  [Sodium selenite reduces acute radiogenic damage of the rat parotid glands during fractionated irradiation].

Authors:  C Sagowski; S Wenzel; S Tesche; L Jenicke; W Kehrl; K Roeser; F U Metternich
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

2.  Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?

Authors:  T Auberger; B Thürriegl; T Freude; L Weissfloch; R Senekowitsch-Schmidke; P Kneschaurek; F M Wagner; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

Review 3.  Blood flow and oxygenation status of human tumors. Clinical investigations.

Authors:  H J Feldmann; M Molls; P Vaupel
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

4.  Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules.

Authors:  S Appold; M Baumann; C Petersen; K Horn; F Eichhorn
Journal:  Strahlenther Onkol       Date:  1998-06       Impact factor: 3.621

5.  Cellular localization, expression, and structure of the nuclear dot protein 52.

Authors:  T Sternsdorf; K Jensen; D Züchner; H Will
Journal:  J Cell Biol       Date:  1997-07-28       Impact factor: 10.539

6.  Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer.

Authors:  Vincent A Potiron; Rym Abderrahmani; Karen Clément-Colmou; Séverine Marionneau-Lambot; Thibauld Oullier; François Paris; Stéphane Supiot
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.